Vomiting  >>  oxaliplatin  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
NCT00381862: Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOX

Completed
2
54
US
aprepitant, Emend, MK-869, L-758,298, L-754,030, dexamethasone, fluorouracil, 5-FU, irinotecan hydrochloride, Trade names: Camptosar®, Other names: Camptothecin-11, CPT-11, leucovorin calcium, Generic Name: Leucovorin, Other Names: Citrovorum Factor, Folinic Acid, oxaliplatin, Trade Name: Eloxatin, palonosetron hydrochloride, Aloxi, quality-of-life assessment
OHSU Knight Cancer Institute, National Cancer Institute (NCI)
Colorectal Cancer, Nausea and Vomiting
03/08
07/08
NCT01017809: Prolonged Emend in a Study (NYU 03-67) of Oxaliplatin and Topotecan in Previously Treated Ovarian Cancer

Withdrawn
2
0
US
Aprepitant, Emend
NYU Langone Health
Ovarian Cancer
12/12
12/13

Download Options